WealthPLAN Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PIMCO Active Bond Exchange-Traded Fund
BOND
|
+$26.6M |
| 2 |
WisdomTree Emerging Markets ex-State-Owned Enterprises Fund
XSOE
|
+$22.3M |
| 3 |
Tortoise North American Pipeline ETF
TPYP
|
+$7.49M |
| 4 |
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
|
+$5.36M |
| 5 |
Altria Group
MO
|
+$3.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
|
+$5.84M |
| 2 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$5.27M |
| 3 |
Acushnet Holdings
GOLF
|
+$2.95M |
| 4 |
Blackstone
BX
|
+$2.65M |
| 5 |
iShares Core Dividend Growth ETF
DGRO
|
+$2.27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 48.79% |
| 2 | Financials | 13.6% |
| 3 | Technology | 8.18% |
| 4 | Consumer Staples | 5.62% |
| 5 | Healthcare | 5.44% |
Similar funds
WealthPLAN Partners's Q4 2019 Portfolio in Review
As of Q4 2019, WealthPLAN Partners held 261 positions worth $847M, up 16% from $732M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
WealthPLAN Partners deployed $65.3M of net new capital in Q4 2019, opening 24 new positions and adding to 118 existing holdings. Its largest new stake was PIMCO Active Bond Exchange-Traded Fund: 245,556 shares worth $26.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, up from 46% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was State Street SPDR S&P 600 Small Cap Value ETF, an estimated $5.84M trimmed.
- WealthPLAN Partners's largest Q4 2019 buy was PIMCO Active Bond Exchange-Traded Fund: 245,556 shares worth $26.9M.
- WealthPLAN Partners added most to State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF in Q4 2019, an estimated $5.36M increase.
- WealthPLAN Partners's biggest Q4 2019 reduction was State Street SPDR S&P 600 Small Cap Value ETF, cutting an estimated $5.84M.
- WealthPLAN Partners fully exited Portola Pharmaceuticals, Inc. in Q4 2019, selling an estimated $1.83M.
- WealthPLAN Partners's ten largest holdings make up 38% of its $847M portfolio in Q4 2019.
- WealthPLAN Partners opened 24 new positions and closed 11 in Q4 2019.
- WealthPLAN Partners's portfolio value rose 16% quarter-over-quarter to $847M.
Based on WealthPLAN Partners's 13F filing for Q4 2019, filed 14 Feb 2020.